Strength
.4 mg/mL
Manufacturer
Eugia US LLCNDC
55150032810
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Last Updated
3/17/2021
Active Ingredients
NALOXONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212456On Market Since
11/4/2019
Pharmacological Classes
Opioid Antagonist
Opioid Antagonists
Related Drugs
Same classification
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00054018813•Hikma Pharmaceuticals USA Inc.
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00121101830•PAI Holdings LLC
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00228315403•Actavis Pharma, Inc.
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00406800503•SpecGx LLC
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00904700906•Major Pharmaceuticals
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
16729054910•Accord Healthcare Inc.
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
42858060103•Rhodes Pharmaceuticals L.P.
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
50268014415•AvPAK
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
60687062665•American Health Packaging
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
62175045232•Lannett Company Inc.
$0.4698
per EA